-

Olympus Adopts AcuityMD Across the Enterprise to Power an Expanding Omnichannel Engagement Strategy

BOSTON--(BUSINESS WIRE)--AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals (HCPs). Olympus is leveraging AcuityMD not only to expand business opportunities but also to continue building its omnichannel strategy and improve the customer experience with personalized engagement.

Olympus sought an industry-specific commercial solution that combines accurate data, analytics, and customer relationship management functionality in one easy-to-use platform. The company adopted AcuityMD’s Targeting Module in 2020 for their Surgical Solutions division and quickly identified new HCPs that can benefit from its products. Olympus is now expanding its use of AcuityMD’s Targeting Module across its Urology, Gastroenterology, and Respiratory business units and is using the platform to further build its omnichannel engagement strategy.

“The customer is at the center of everything we do,” said Suzan Morgan, head of omnichannel strategy at Olympus. “AcuityMD’s platform not only makes it faster to identify physicians whose patients could benefit from Olympus solutions, but it also enables more personalized engagement in more accessible ways. For instance, our sales reps get rich insights from the system to better prepare for business review meetings and ensure a relevant discussion that benefits each physician.”

“We’ve built a true partnership with AcuityMD over the years,” said Michael Fleming, vice president of commercial operations at Olympus. “AcuityMD has been instrumental in streamlining our sales operations and building our pipeline, and we are excited to expand the relationship.”

AcuityMD is filling a void for a data-driven commercialization platform that helps MedTech companies identify high-value opportunities to deliver their innovative products that improve and save lives. MedTech companies have traditionally relied on one-size-fits-all CRM software coupled with cumbersome data exports to reach potential customers. AcuityMD’s platform transforms large volumes of healthcare data, such as procedural volumes, where surgeons operate, and peer networks, into intuitive workflows that prioritize sales efforts and align with the industry’s commercialization process.

"It is especially rewarding to see how our platform has positively impacted Olympus’ sales performance and omnichannel goals over the past months, and we are excited to grow with them,” said Michael Monovoukas, CEO and co-founder of AcuityMD. “With this expansion, we aim to unlock even greater efficiencies for Olympus and continue to streamline the process of bringing their live-saving innovations to patients.”

Olympus will be presenting at AcuityMD’s first annual conference, Flywheel, September 26 in Boston. For more information, contact lbarbadora@barbadoraink.com.

About AcuityMD

AcuityMD is a leading technology partner to the commercial MedTech industry. Thousands of sales and marketing professionals use AcuityMD’s commercial platform to identify target markets, surface top opportunities, and grow their business. With customers ranging from pre-commercial to enterprise, AcuityMD is committed to providing MedTech companies with unparalleled visibility to accelerate adoption of medical technology.

Contacts

Lisa Barbadora, Barbadora INK for AcuityMD
+1 (610) 420-3413
lbarbadora@barbadoraink.com

AcuityMD


Release Versions

Contacts

Lisa Barbadora, Barbadora INK for AcuityMD
+1 (610) 420-3413
lbarbadora@barbadoraink.com

More News From AcuityMD

AcuityMD Brings Early Signals to AcuityAI, Helping MedTech Sales Teams Spot Changes in Physician Activity Sooner

BOSTON--(BUSINESS WIRE)--AcuityMD, the AI platform for MedTech, today announced the availability of Early Signals in AcuityAI, giving commercial teams earlier visibility into potential changes in healthcare provider (HCP) procedure activity. Drawing on recent medical claims data, AcuityAI can identify early indicators that a physician may have started performing a procedure they had not performed previously. This intelligence also helps sales reps target new physicians and engage them ahead of...

AcuityAI Now Includes Health Network Data to Help MedTech Teams Uncover Opportunities Across Entire Health Systems

BOSTON--(BUSINESS WIRE)--AcuityMD, the AI platform for MedTech, today announced the availability of health network intelligence in AcuityAI, giving MedTech commercial teams a comprehensive view of healthcare sites, sales performance, and opportunities across health systems and purchasing networks. Sales teams can ask AcuityAI about integrated delivery networks (IDNs), group purchasing organizations (GPOs), regional purchasing coalitions (RPCs), and management services organizations (MSOs) and g...

AcuityMD Launches AcuityAI Artifacts to Turn Chat Insights Into Structured, Shareable Outputs

BOSTON--(BUSINESS WIRE)--AcuityMD, the AI platform for MedTech, today announced AcuityAI Artifacts, a new capability that transforms AI-generated insights into structured, reusable content for commercial teams. With Artifacts, users can turn AcuityAI conversations into call plans, market analyses, account comparisons, targeting lists, and reports that can be easily saved, refined, and exported. Artifacts ensure valuable insights extend beyond a single conversation, enabling teams to continuousl...
Back to Newsroom